Urinary incontinence differential diagnosis: Difference between revisions
No edit summary |
|||
Line 24: | Line 24: | ||
! colspan="4" rowspan="4" |Type of incontinence | ! colspan="4" rowspan="4" |Type of incontinence | ||
! colspan="10" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ! colspan="10" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ||
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para−clinical findings | ||
! colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 61: | Line 61: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |± | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | ++ | | align="center" style="background:#F5F5F5;" + | ++ | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |↑/↓ | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |< 50 ml | | align="center" style="background:#F5F5F5;" + |< 50 ml | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |Pyuria | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |NA | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 85: | Line 85: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 109: | Line 109: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 131: | Line 131: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Altered mental status]] | ! align="center" style="background:#DCDCDC;" + |[[Altered mental status]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 155: | Line 155: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Spinal cord injury|Traumatic spinal cord injury]] | ! align="center" style="background:#DCDCDC;" + |[[Spinal cord injury|Traumatic spinal cord injury]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |± | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 180: | Line 180: | ||
! align="center" style="background:#DCDCDC;" + |[[Multiple sclerosis]] | ! align="center" style="background:#DCDCDC;" + |[[Multiple sclerosis]] | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 188: | Line 188: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 230: | Line 230: | ||
! align="center" style="background:#DCDCDC;" + |[[Benign prostatic hyperplasia]] | ! align="center" style="background:#DCDCDC;" + |[[Benign prostatic hyperplasia]] | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 255: | Line 255: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 279: | Line 279: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 301: | Line 301: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Uterine fibroids]] | ! align="center" style="background:#DCDCDC;" + |[[Uterine fibroids]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 309: | Line 309: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 325: | Line 325: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Uterine prolapse]] | ! align="center" style="background:#DCDCDC;" + |[[Uterine prolapse]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |± | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 350: | Line 350: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gastrointestinal diseases | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gastrointestinal diseases | ||
! align="center" style="background:#DCDCDC;" + |[[Fecal impaction]] | ! align="center" style="background:#DCDCDC;" + |[[Fecal impaction]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 358: | Line 358: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 374: | Line 374: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Rectal prolapse]] | ! align="center" style="background:#DCDCDC;" + |[[Rectal prolapse]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 382: | Line 382: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 439: | Line 439: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ability hold urge | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ability hold urge | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Nocturia | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Nocturia | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Post−void residual volume | ||
|- | |- | ||
|Urge incontinence (detrusor instability) | |Urge incontinence (detrusor instability) | ||
Line 448: | Line 448: | ||
* Benign prostatic hyperplasia (BPH) | * Benign prostatic hyperplasia (BPH) | ||
| | | | ||
* 9% in women age | * 9% in women age 40−44 years | ||
* 31% in women older than 75 years | * 31% in women older than 75 years | ||
* 42% in men older than 75 years | * 42% in men older than 75 years | ||
| | | | ||
* Detrusor overactivity | * Detrusor overactivity | ||
* Increased parasympathetic drive to the bladder ( | * Increased parasympathetic drive to the bladder (S2−S4) | ||
| | | | ||
* Variable amount of urine loss; ranging from small volumes to complete emptying of the bladder | * Variable amount of urine loss; ranging from small volumes to complete emptying of the bladder | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | |− | ||
| | | | ||
* Small to large volume | * Small to large volume | ||
| | |− | ||
|<nowiki>++</nowiki> | |<nowiki>++</nowiki> | ||
|< 50 ml | |< 50 ml | ||
Line 474: | Line 474: | ||
* Multiple childbirths | * Multiple childbirths | ||
| | | | ||
* | * 25−45% in women > 30 years | ||
| | | | ||
* Weakness of the uretheral sphincter | * Weakness of the uretheral sphincter | ||
Line 481: | Line 481: | ||
* Patient recognizes which activities promote incontinence | * Patient recognizes which activities promote incontinence | ||
* Incontinence with cough, sneezing, straining | * Incontinence with cough, sneezing, straining | ||
| | |− | ||
| | |− | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
* Small volume | * Small volume | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | +/− | ||
|< 50 ml | |< 50 ml | ||
| | | | ||
Line 507: | Line 507: | ||
| | | | ||
* Poor bladder emptying | * Poor bladder emptying | ||
* | * Post−void urine volume > 200−300 ml | ||
| | |− | ||
| | |− | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
Line 517: | Line 517: | ||
|> 200 ml | |> 200 ml | ||
| | | | ||
* | * Alpha−adrenergic blockers: | ||
** Tamsulosin | ** Tamsulosin | ||
** Terazosin | ** Terazosin | ||
Line 532: | Line 532: | ||
* Genitourinary surgical procedures | * Genitourinary surgical procedures | ||
* Multiple childbirths | * Multiple childbirths | ||
| | |− | ||
| | | | ||
* Combined urge and stress incontinence | * Combined urge and stress incontinence | ||
| | | | ||
* Patient able to determine the | * Patient able to determine the pre−dominant symptoms | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | +/− | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
* Variable volume | * Variable volume | ||
| | | +/− | ||
| | | +/− | ||
|Variable | |Variable | ||
| | | | ||
Line 551: | Line 551: | ||
| | | | ||
* Altered mental status | * Altered mental status | ||
| | |− | ||
| | | | ||
* Inability to reach the toilet to urinate | * Inability to reach the toilet to urinate | ||
Line 559: | Line 559: | ||
* Immobility | * Immobility | ||
* Lower urinary tract deficits | * Lower urinary tract deficits | ||
| | |− | ||
| | |− | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
Line 568: | Line 568: | ||
|< 50 ml | |< 50 ml | ||
| | | | ||
* | * Cause−dependent | ||
|} | |} | ||
Revision as of 15:06, 22 May 2018
Urinary incontinence Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Urinary incontinence differential diagnosis On the Web |
American Roentgen Ray Society Images of Urinary incontinence differential diagnosis |
Risk calculators and risk factors for Urinary incontinence differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Syed Hassan A. Kazmi BSc, MD [3]
Overview
Urinary incontinence may have different etiologies depending upon the underlying dysfunction. The various types of urinary incontinence should be differentiated from each other for optimal management.
Differential diagnosis of urinary incontinence
The following table differentiates the various types of urinary incontinence:[1][2][3][4][5][6][7][8]
To review differential diagnosis of urge incontinence, click here.
To review differential diagnosis of stress incontinence, click here.
To review differential diagnosis of functional incontinence, click here.
To review differential diagnosis of overflow incontinence, click here.
To review differential diagnosis of mixed incontinence, click here.
Category | Diseases | Type of incontinence | Clinical manifestations | Para−clinical findings | Gold standard | Additional findings | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | ||||||||||||||||||||||
Lab Findings | Imaging | ||||||||||||||||||||||
Loss of consciousness | Fever | Abdominal pain | Urinary symptoms | BP | Edema | Neurological deficit | Urine residue | UA | Other | Ultrasound | CT scan | Other | |||||||||||
Urge | Stress | Functional | Overflow | Dysuria | Frequency | Dribbling | Nocturia | ||||||||||||||||
Neurological diseases | Stroke | + | + | − | − | + | − | − | ± | + | + | ++ | ↑/↓ | − | + | < 50 ml | Pyuria | NA | |||||
Alzheimer's disease | + | + | − | − | + | + | ++ | < 50 ml | |||||||||||||||
Parkinson's disease | + | + | − | − | + | + | ++ | < 50 ml | |||||||||||||||
Altered mental status | − | − | + | − | − | + | + | < 50 ml | |||||||||||||||
Traumatic spinal cord injury | − | + | − | − | − | + | ± | < 50 ml | |||||||||||||||
Multiple sclerosis | + | − | − | + | + | − | + | > 200 ml | |||||||||||||||
Category | Diseases | Urge | Stress | Functional | Overflow | Loss of consciousness | Fever | Abdominal pain | Dysuria | Frequency | Dribbling | Nocturia | BP | Edema | Neurological deficit | Urine residue | UA | Other | Ultrasound | CT scan | Other | Gold standard | Additional findings |
Urogenital disorders | Benign prostatic hyperplasia | + | − | − | + | + | + | + | > 200 ml | ||||||||||||||
Genitourinary surgical procedures | + | + | − | − | + | + | + | < 50 ml | |||||||||||||||
Multiple childbirths | + | + | − | − | + | + | + | < 50 ml | |||||||||||||||
Uterine fibroids | − | − | − | + | − | + | + | > 200 ml | |||||||||||||||
Uterine prolapse | − | + | − | − | − | + | ± | < 50 ml | |||||||||||||||
Gastrointestinal diseases | Fecal impaction | − | − | − | + | − | + | + | > 200 ml | ||||||||||||||
Rectal prolapse | − | − | − | + | − | + | + | > 200 ml | |||||||||||||||
Category | Diseases | Urge | Stress | Functional | Overflow | Loss of consciousness | Fever | Abdominal pain | Dysuria | Frequency | Dribbling | Nocturia | BP | Edema | Neurological deficit | Urine residue | UA | Other | Ultrasound | CT scan | Other | Gold standard | Additional findings |
Type Of Incontinence | Causes | Prevalence | Pathophysiology | History Findings | Signs and symptoms | Management | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Urgency | Frequency
(> 8 times/day) |
Dribbling of urine | Amount of dribbling with each episode of incontinence | Ability hold urge | Nocturia | Post−void residual volume | ||||||
Urge incontinence (detrusor instability) |
|
|
|
|
+ | + | − |
|
− | ++ | < 50 ml |
|
Stress incontinence |
|
|
|
|
− | − | + |
|
+ | +/− | < 50 ml |
|
Overflow incontinence |
|
|
|
|
− | − | + |
|
+ | + | > 200 ml |
|
Mixed incontinence (urge and stress) |
|
− |
|
|
+ | +/− | + |
|
+/− | +/− | Variable |
|
Functional incontinence |
|
− |
|
|
− | − | + |
|
+ | + | < 50 ml |
|
References
- ↑ "pdfs.semanticscholar.org" (PDF).
- ↑ Brown JS, Bradley CS, Subak LL, Richter HE, Kraus SR, Brubaker L, Lin F, Vittinghoff E, Grady D (May 2006). "The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence". Ann. Intern. Med. 144 (10): 715–23. PMC 1557357. PMID 16702587.
- ↑ Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE (March 2008). "What type of urinary incontinence does this woman have?". JAMA. 299 (12): 1446–56. doi:10.1001/jama.299.12.1446. PMID 18364487.
- ↑ Videla FL, Wall LL (June 1998). "Stress incontinence diagnosed without multichannel urodynamic studies". Obstet Gynecol. 91 (6): 965–8. PMID 9611005.
- ↑ DuBeau CE, Kuchel GA, Johnson T, Palmer MH, Wagg A (2010). "Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence". Neurourol. Urodyn. 29 (1): 165–78. doi:10.1002/nau.20842. PMID 20025027.
- ↑ "Diagnosis of Urinary Incontinence - American Family Physician".
- ↑ Frank C, Szlanta A (November 2010). "Office management of urinary incontinence among older patients". Can Fam Physician. 56 (11): 1115–20. PMC 2980426. PMID 21075990.
- ↑ Imam KA (2004). "The role of the primary care physician in the management of bladder dysfunction". Rev Urol. 6 Suppl 1: S38–44. PMC 1472846. PMID 16985854.